Meilong Shi

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Kailian Zheng · 3 shared papers, 2026 · strength 0.59
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
2. Xiongfei Xu · 3 shared papers, 2026 · strength 0.59
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
3. Xiaoyi Yin · 3 shared papers, 2026 · strength 0.59
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
4. Gang Jin · 3 shared papers, 2026 · strength 0.59
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
5. Yehan Zhang · 2 shared papers, 2026 · strength 0.39
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
6. Lingyu Zhu · 2 shared papers, 2026 · strength 0.39
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
7. Yunguang Li · 2 shared papers, 2026 · strength 0.39
   • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
   • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
8. Jie Li · 1 shared paper, 2026 · strength 0.26
   • Paper Transcriptomic landscape of transposable elements reveals LTR7-PLAAT4 as a potential oncogene and therapeutic target in… DOI 10.1101/gr.280528.125↗
9. Suizhi Gao · 1 shared paper, 2026 · strength 0.20
   • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
10. Shiwei Guo · 1 shared paper, 2026 · strength 0.20
    • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
11. Eric Tran · 1 shared paper, 2026 · strength 0.20
    • Paper T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical tria… DOI 10.1016/j.ymthe.2026.03.012↗
12. Huan Wang · 1 shared paper, 2026 · strength 0.20
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗
13. Huan Wang · 1 shared paper, 2026 · strength 0.20
    • Paper Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-… DOI 10.1016/j.canlet.2026.218298↗
14. Xiaohan Shi · 1 shared paper, 2026 · strength 0.20
    • Paper The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant ther… DOI 10.1016/j.canlet.2026.218252↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.